Executive Profiles

How Emerging Biopharmas Can Obtain VC Funding

January 24, 2020

Ken Shimokawa, Founder and General Partner of G4S Capital, shares insights into what venture capitalists look for when evaluating emerging biopharmaceutical opportunities.

Managed Access to Rare Disease Medicines

January 23, 2020

Natalie Douglas talks about her experience in the area of managed and expanded access and her new venture, RareiTi.

Putting CADTH on the National and International Stage

January 20, 2020

Leela Barham talks to Dr. Brian O’Rourke, outgoing President and Chief Executive Officer of the Canadian Agency for Drugs and Technologies in Health (CADTH), about his 11 in years in the role.

Paving Bayer’s Future Path

January 14, 2020

Led in part by its new head of the Americas business, Sebastian Guth, Bayer went all in in 2019 on expanding pursuits in science and discovery, striking deals with 11 digital health startups and upping investment in disease-detection programs and patient engagement and education.

AstraZeneca's CVRM Path

January 13, 2020

AstraZeneca's Joris Silon outlines the company's efforts in CVRM (Cardiovascular, Renal and Metabolism) and the potential impact on type-2 diabetes and chronic kidney disease of SGLT2 inhibitors such as Forxiga.

Deeper Dive: Gene Therapy Manufacturing

January 01, 2020

Hari Pujar, chief technology officer of Spark Therapeutics, discusses the unique manufacturing and scale-up challenges involved with cell and gene therapy production.

Planning Ahead with Korn Ferry's Dr. Paul Pospisil

December 19, 2019

Korn Ferry's Dr. Paul Pospisil talks to HBSHAA's Michael Wong about why biopharma employees should be excited about the industry's prospects.

Lundbeck's Taj Bhardwaj: Market Access and Mental Health

December 17, 2019

Lundbeck executive Taj Bhardwaj talks about the differing mindsets necessary to lead local and global-level market access strategy in pharma-and how his current company is committed to stay in the fight to advance new treatments and break down stigmas in mental health.

Unprecedented Times for Market Access: Amy Mahery

December 16, 2019

Amy Mahery, last month appointed Global Head of Market Access and Pricing of the healthcare business of Merck KGaA, Darmstadt, Germany, discusses her key priorities and how she will draw on her multi-faceted industry experience to approach the challenges ahead.

Digital Innovation from Microscope to Market: Kaisa Helminen, Aiforia Technologies

November 15, 2019

Aiforia Technologies CEO Kaisa Helminen talks about the benefits of pharma embracing digital technologies, especially AI-assisted image analysis in the field of histopathology.